{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T06:55:38Z","timestamp":1775285738730,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1994,2,1]],"date-time":"1994-02-01T00:00:00Z","timestamp":760060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1994,2]]},"DOI":"10.1007\/bf02245440","type":"journal-article","created":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T15:00:47Z","timestamp":1133449247000},"page":"24-30","source":"Crossref","is-referenced-by-count":20,"title":["A long-term cross-over pharmacokinetic study comparing perphenazine decanoate and haloperidol decanoate in schizophrenic patients"],"prefix":"10.1007","volume":"114","author":[{"given":"S. J.","family":"Dencker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Gi\u00f6s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"M\u00e5rtensson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Nord\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Nyberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Persson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Stockman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. -O.","family":"Sv\u00e4rd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02245440_CR1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0278-5846(90)90061-K","volume":"14","author":"CA Altamura","year":"1990","unstructured":"Altamura CA, Colarcurcio F, Mauri MC, Moro AR, De Novellis F (1990). Haloperidol Decanoat in Chronic Schizophrenia: A study of 12 months with plasma levels. Prog Neuropsychopharmacol Biol Psychiatry 14:25\u201335","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BF02245440_CR2","unstructured":"Bech P, Malt U, Dencker SJ et al. (1993) Scales for assessment of diagnosis and severity of mental disorders. Acta Psychiatr Scand Suppl 372"},{"key":"BF02245440_CR3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2165\/00003088-198611010-00003","volume":"11","author":"SG Dahl","year":"1986","unstructured":"Dahl SG (1986) Plasma level monitoring of antipsychotic drugs clinical utility. Clin Pharmacokinet 11:36\u201361","journal-title":"Clin Pharmacokinet"},{"issue":"61","key":"BF02245440_CR4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1600-0447.1980.tb07080.x","volume":"Suppl 279","author":"SJ Dencker","year":"1980","unstructured":"Dencker SJ, Lepp M, Malm U (1980) Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. I. A one year double-blind study of clopenthixol decanoate and flupenthixol palmitate. Acta Psychiatr Scand Suppl 279[61]:10\u201328","journal-title":"Acta Psychiatr Scand"},{"issue":"14","key":"BF02245440_CR5","first-page":"7","volume":"Suppl 2","author":"K Eklund","year":"1991","unstructured":"Eklund K, Forsman A (1991) Minimal effective dose and relapse \u2014 double-blind trial: haloperidol vs placebo. Clin Neuropharmacol Suppl 2[14]:7\u201315","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"BF02245440_CR6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF00501606","volume":"286","author":"A Forsman","year":"1974","unstructured":"Forsman A, M\u00e5rtensson E, Nyberg G, \u00d6hman R (1974) A gas chromatographic method for determining haloperidol. A sensitive procedure for studying serum concentration and pharmacokinetics of haloperidol in patients. Naunyn Schmiedebergs Arch Pharmacol 286[2]:113\u2013124","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"BF02245440_CR7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0889-8529(18)30442-0","volume":"17","author":"AI Green","year":"1988","unstructured":"Green AI, Brown WA (1988) Prolactin and neuroleptic drugs. Endocrinol Metab Clin N Am 17:213\u2013223","journal-title":"Endocrinol Metab Clin N Am"},{"key":"BF02245440_CR8","volume-title":"Guidelines for neuroleptic relapse prevention in schizophrenia","year":"1991","unstructured":"Kissling W (ed) (1991) Guidelines for neuroleptic relapse prevention in schizophrenia. Springer, Berlin Heidelberg"},{"key":"BF02245440_CR9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF02316862","volume":"105","author":"K Kistrup","year":"1991","unstructured":"Kistrup K, Gerlach J, Aaes-J\u00f6rgensen T, Larsen N-E (1991) Perphenazine decanoate and cis(z)-flupentixol decanoate in maintenance treatment of schizophrenic outpatients. Psychopharmacology 105:42\u201348","journal-title":"Psychopharmacology"},{"issue":"72","key":"BF02245440_CR10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-0447.1985.tb08540.x","volume":"Suppl 322","author":"P Knudsen","year":"1985","unstructured":"Knudsen P, Hansen LB, Larsen N-E (1985a) Depot neuroleptic treatment: Clinical and pharmacokinetic studies of pephenazine decanoate. Acta Psychiatr Scand Suppl 322[72]:51\u201374","journal-title":"Acta Psychiatr Scand"},{"key":"BF02245440_CR11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-0447.1985.tb08538.x","volume":"72","author":"P Knudsen","year":"1985","unstructured":"Knudsen P, Hansen LB, H\u00f6jholdt K, Larsen N-E (1985b) Long-term depot neuroleptic treatment with perphenazine decanoate I: efficacy and side effects in a 12 month study of 42 drug monitored psychiatric patients. Acta Psychiatr Scand Suppl 322[72]:29\u201340","journal-title":"Acta Psychiatr Scand"},{"key":"BF02245440_CR12","first-page":"1071","volume":"36","author":"M Larsson","year":"1984","unstructured":"Larsson M, Axelsson R, Forsman A (1984) On the pharmacokinetics of perphenazine: a clinical study of perphenazine enanthate and decanoat. Curr Ther Res 36:1071\u20131088","journal-title":"Curr Ther Res"},{"key":"BF02245440_CR13","unstructured":"Lingj\u00e6rde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987) The UKU side effect rating scale. Acta Psychiatr Scand 334. 76."},{"key":"BF02245440_CR14","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1192\/bjp.158.5.658","volume":"158","author":"SR Marder","year":"1991","unstructured":"Marder SR, Midha KK, Van Putten T, Aravagiri M, Hawes EM, Hubbard JW, McKay G, Mintz J (1991) Plasma levels of fluphenazine in patients receiving fluphenazine decanoate relationship to clinical response. Br J Psychiatry 158:658\u2013665","journal-title":"Br J Psychiatry"},{"key":"BF02245440_CR15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1192\/bjp.151.3.333","volume":"151","author":"JP McKane","year":"1987","unstructured":"McKane JP, Robinson ADT, Wiles DH, McCreadie RG, Stirling GS (1987) Haloperidol decanoat v. Fluphenazine decanoate as maintenance therapy in chronic schizophrenic in-patients. Br J Psychatry 151:333\u2013336","journal-title":"Br J Psychatry"},{"key":"BF02245440_CR16","unstructured":"Muuze RG (1980) Determination of serum levels of psychotropic drugs by liquid-solid chromatography. Proceedings of the 4th International Symposium on phenothiazines and structurally related drugs, pp 125\u2013172"},{"key":"BF02245440_CR17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0278-5846(89)90013-4","volume":"13","author":"M Om\u00e9rov","year":"1988","unstructured":"Om\u00e9rov M, Wistedt B, Hansen-Bolvig L, Larsen N-E (1988) The relationship between perphenazine plasma levels and clinical response in acute schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 13:159\u2013166","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BF02245440_CR18","unstructured":"Perris C (1974) A multicentre multidimensional study of some new longacting neuroleptic drugs. Acta Psychiatr Scand Suppl 249"},{"key":"BF02245440_CR19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000468580","volume":"17","author":"AJM Reyntjens","year":"1982","unstructured":"Reyntjens AJM, Heykants JJP, Woestenborghs RJH, Gelders YG, Aers TJL (1982) Pharmacokinetics of haloperidol decanoate. A 2-year follow-up. Int Pharmacopsychiatry 17:238\u2013246","journal-title":"Int Pharmacopsychiatry"},{"key":"BF02245440_CR20","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1192\/bjp.161.6.797","volume":"161","author":"K Skantze","year":"1992","unstructured":"Skantze K, Malm U, Dencker SJ, May PRA, Corrigan P (1992) Comparison of quality of life to standard of living in schizophrenic outpatients. Br J Psychiatriatry 161:797\u2013801","journal-title":"Br J Psychiatriatry"},{"key":"BF02245440_CR21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1600-0447.1989.tb01336.x","volume":"80","author":"K Thapa","year":"1989","unstructured":"Thapa K, Rowland LA (1989) Quality of life perspective sin long-term care: staff and patient perceptions. Acta Psychiatr Scand 80:267\u2013271","journal-title":"Acta Psychiatr Scand"},{"key":"BF02245440_CR22","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/archpsyc.1992.01820050018002","volume":"49","author":"J Volavka","year":"1992","unstructured":"Volavka J, Cooper T, Czobor P, Bitter I, Meisner M, Laska E, Gastanaga P, Krakowski M, Chou C-YJ, Crowner M, Douyon R (1992) Haloperidol blood levels and clinical effects. Arch Gen Psychiatry 49:354\u2013361","journal-title":"Arch Gen Psychiatry"},{"key":"BF02245440_CR23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0447.1981.tb00761.x","volume":"64","author":"B Wistedt","year":"1981","unstructured":"Wistedt B (1981) A depot neuroleptic withdrawal study: a controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients. Acta Psychiatr Scand 64:65\u201384","journal-title":"Acta Psychiatr Scand"},{"key":"BF02245440_CR24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF00433729","volume":"78","author":"B Wistedt","year":"1982","unstructured":"Wistedt B, J\u00f6rgensen A, Wiles D (1982) A depot neuroleptic withdrawal study. Plasma concentrations of fluphenazine and flupenthixol and relapse frequency. Psychopharmacology 78:301\u2013304","journal-title":"Psychopharmacology"},{"issue":"1","key":"BF02245440_CR25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0447.1991.tb01414.x","volume":"84","author":"B Wistedt","year":"1991","unstructured":"Wistedt B, Koskinen T, Thelander S, Nerdrum T, Pedersen V, M\u00f6lbjerg C (1991) Zuclopenthixol decanoate and haloperidol decanoate in chronic schizophrenia: a double-blind multicentre study. Acta Psychiatr Scand 84[1]:14\u201322","journal-title":"Acta Psychiatr Scand"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02245440.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02245440\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02245440","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T07:40:21Z","timestamp":1706773221000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02245440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994,2]]}},"alternative-id":["BF02245440"],"URL":"https:\/\/doi.org\/10.1007\/bf02245440","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,2]]}}}